Reaction
Arthrodesis reporting signals
As of the last recalculation, Arthrodesis appears in 1,004 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is CEFAZOLIN (PRR 170.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cefazolin | 70 | 170.9 | 172.2 |
| Cefazolin Sodium | 70 | 129.4 | 130.1 |
| Anakinra | 57 | 75.5 | 75.7 |
| Desoximetasone | 52 | 59.6 | 59.8 |
| Tofacitinib Citrate | 32 | 52.2 | 52.4 |
| Tenofovir Disoproxil Fumarate | 69 | 46.4 | 46.5 |
| Leflunomide | 175 | 41.8 | 41.8 |
| Hydroxychloroquine Sulfate | 147 | 39.0 | 39.1 |
| Sulfasalazine | 124 | 37.3 | 37.4 |
| Abatacept | 194 | 35.8 | 35.8 |
| Golimumab | 108 | 29.1 | 29.2 |
| Tocilizumab | 134 | 27.9 | 28.0 |
| Baricitinib | 11 | 23.9 | 23.9 |
| Certolizumab Pegol | 119 | 23.7 | 23.8 |
| Drs. Clotrimazole | 13 | 23.6 | 23.6 |
| Family Wellness Clotrimazole | 13 | 23.6 | 23.6 |
| Clotrimazole Topical | 13 | 23.6 | 23.6 |
| Desloratadine | 12 | 23.5 | 23.5 |
| Naproxen | 80 | 22.9 | 22.9 |
| Clotrimazole | 13 | 22.2 | 22.2 |
| Hydroxychloroquine | 72 | 21.5 | 21.5 |
| Methotrexate | 307 | 21.3 | 21.4 |
| Methotrexate Sodium | 335 | 20.9 | 21.0 |
| Infliximab | 173 | 19.6 | 19.7 |
| Ketoconazole | 16 | 19.5 | 19.5 |
| Adalimumab | 391 | 18.1 | 18.1 |
| Upadacitinib | 62 | 16.7 | 16.8 |
| Tofacitinib | 120 | 15.2 | 15.2 |
| Etanercept | 276 | 12.8 | 12.8 |
| Crisaborole | 5 | 10.9 | 10.9 |
| Cannabidiol | 9 | 8.0 | 8.0 |
| Sarilumab | 8 | 6.3 | 6.3 |